Figure 2.

Preparation process of DOX-loaded PMLG₇-b-PLGA₂₂ and PGLG₇-b-PLGA₂₂ micelles and evaluation of the antitumor efficacy ¹⁰⁹. (A) Preparation and targeted delivery of micelles assembled from glycopeptide and DOX. (B) Antitumor efficacies in vivo, (C) and body weight changes treated with PBS, DOX, and micelles from PMLG₇-b-PLGA₂₂/DOX and PGLG₇-b-PLGA₂₂/DOX. Evaluation of (D) ALT, (E) AST, (F) BUN, (G) Cr, (H) CK, and (I) LDH levels after all the treatments of PBS, DOX, and nanomedicines from PMLG₇-b-PLGA₂₂/DOX and PGLG₇-b-PLGA₂₂/DOX. Copyright 2013. Reproduced with permission from Elsevier Ltd.